DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Applicant’s amendment and accompanying remarks filed August 31, 2026 are acknowledged.
Examiner acknowledges amended claims 1 and 10.
Examiner acknowledges pending claims 1-4, 10-11, 14, 23, 26,33-34, 36-37, 40-41 and 45-49.
Examiner acknowledges cancelled claims 5-9, 12-13, 15-22, 24-26. 27-32, 35, 38-39 and 42-44.
The rejection of claims 1-4, 10-11, 14, 23, 26,33-34, 36-37, 40 and 45-49 under 35 U.S.C. 103 as being unpatentable over Zimmerman, GB1150860 in view of Huelsmann et al., U.S. Pre Grant Publication 2015/0099847 is overcome by Applicant’s amendment.
The rejection of claim 41 under 35 U.S.C. 103 as being unpatentable over Zimmerman, GB1150860 in view of Huelsmann et al., U.S. Pre Grant Publication 2015/0099847 and in further view of Kia et al., U.S. Pre Grant Publication 2017/0136698 is overcome by Applicant’s amendment.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claims 1-4, 10-11, 14, 23, 26, 34, 36-37, 40-41 and 45-49.are rejected under 35 U.S.C 102(a)(1) as being anticipated by Wenzel et al., U.S. Patent Number 5,360,891 as evidenced by Prince et al., The effect of Isomer Ratio on the Properties Bis(4-aminocyclohexyl)methane Polyamides
Regarding claims 1-4, 10-11, 14, 23 26, 34,36, and 45-40, Wenzel discloses a polyimide composition comprising I. 35-60 mol% of trans,trans bis(4-aminocyclohexyo)-methane and II 65-40 mol% of other aliphatic, cycloaliphatic, araliphatic or aromatic diamines. [see abstract and column 2, lines 5-19[] wherein the molar ratio of components I and II ranges from 0.95 to 1.05:1. Column 3, lines 34-36 discloses that the composition can include fillers and stabilizers. It is disclosed in column 3, lines 37-38 that the composition can be processed into fibers. Column 3, lines 1-6 discloses that the suitable acid components I can include decanedioic acid which yields n=10.
PNG
media_image1.png
155
840
media_image1.png
Greyscale
[recurring unit].
Prince et al., provides for a glass transition temperature and melt temperature of the bis(4-aminocyclohexyl)methane polyamide when n=10 [as in Wenzel]. Table 1 of Prince discloses Tm [melt temperature] is 264 ºC and a Tg [glass transition temperature] of 125 ºC.
Regarding claim 37, reference claim 13 discloses a process by extrusion.
Regarding claim 41, reference claims 15-17 disclose a 3_D object such as an inspection window or lamp cover.
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
Claim 33 is rejected under 35 U.S.C. 103 as being unpatentable over Wenzel et al., U.S. Patent Number 5,360,891 as evidenced by Prince et al., The effect of Isomer Ratio on the Properties Bis(4-aminocyclohexyl)methane Polyamides in view of Zimmerman, GB1150860.
Wenzel, as evidenced by Prince, remains relied upon for claim 1.
Wenzel, as evidenced by Prince, is silent to the geometry and diameter of the filament. Zimmerman discloses polyamide filaments [title]. It is disclosed in page 1, lines 29-50 of Zimmerman a high molecular crystalline oriented filament of trans,trans bis(4-(aminocyclohexyl) methane wherein n = 10 [see paragraphs 0003-0005]. Zimmerman discloses in column 4, lines 32-35 that the filament has a diameter 0.12 to 1.25 mm. A filament has a cylindrical shape. Zimmerman discloses that the fiber has high strength, high modulus and low shrinkage [0027]. Wenzel and Zimmerman are analogous art in that both references discloses polyamide filaments formed from bis(4-aminocyclohexyl)methane polyamides wherein n=10. One of ordinary skill in the art before the effective filing date of the invention would optimize the diameter of the filament in Wenzel in the range of 0.5 mm to 5.0 mm for the benefit of having a filament with enhanced strength, modulus and low shrinkage.
Response to Arguments
Applicant’s arguments with respect to the present claims have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument.
Applicant has amended the claims to recite the glass transition temperature and the melting temperature. Applicant’s previous claim set [claim 10] recited the glass transition temperature and/or the melting temperature. Applicant narrowed the scope of the claims.
Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to CAMIE S THOMPSON whose telephone number is (571)272-1530. The examiner can normally be reached 8:30 am - 5:30 pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Boyd, can be reached at 571-272-7783. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/CAMIE S THOMPSON/Primary Examiner, Art Unit 1786